Arkolith/Insider Trading/AVTE/Form 4

Gillies Hunter

CHIEF MEDICAL OFFICERAerovate Therapeutics, Inc. (AVTE) · full profile →Form 4 · filed Apr 1, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$266K
Net Open-Market Flow
-$266K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 28, 2024Sell(S)9K$29.50$266K3K
Mar 28, 2024Option exercise(M)9K$2.14$19K12K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 28, 2024Option exercise(M)9K—$090K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-009596) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML